Similar articles

• Quality of life and life expectancy in thalassemic patients with complications.

  Gabutti V, Piga A, Sacchetti L, Sandri A, Biginelli M, Saracco P, Ferri M. Gabutti V, et al. Prog Clin Biol Res. 1989;309:35-41. Prog Clin Biol Res. 1989. PMID: 2780748 No abstract available.
• Endocrine complications in patients with Thalassaemia Major.

  Toumba M, Sergis A, Kanaris C, Skordis N. Toumba M, et al. Pediatr Endocrinol Rev. 2007 Dec;5(2):642-8. Pediatr Endocrinol Rev. 2007. PMID: 18084158 Review.
• Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

  Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A. Borgna-Pignatti C, et al. Haematologica. 2004 Oct;89(10):1187-93. Haematologica. 2004. PMID: 15477202
• Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.

  Karamifar H, Shahriari M, Sadjadian N. Karamifar H, et al. East Mediterr Health J. 2003 Jan-Mar;9(1-2):55-60. East Mediterr Health J. 2003. PMID: 15562733
• [Severe chronic anemia and endocrine disorders in children].

  Hauschild M, Theintz G. Hauschild M, et al. Rev Med Suisse. 2007 Apr 18;3(107):988-91. Rev Med Suisse. 2007. PMID: 17526372 Review. French.